| Incentive and Non-statutory Stock Option Plan |
NOTE 16 - INCENTIVE AND NON-STATUTORY STOCK OPTION PLAN
Common stock purchase options and warrants consisted of the following:
OPTIONS:
| |
|
# of shares |
|
|
Weighted Ave
Exercise Price
|
|
|
Weighted
Average
Remaining
Contractual
Life (in years)
|
|
|
Aggregated
Intrinsic Value
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding and exercisable, June 30, 2016 |
|
|
610,133 |
|
|
$ |
4.90 |
|
|
|
0.99 |
|
|
$ |
799,030 |
|
| Granted |
|
|
79,838 |
|
|
$ |
4.53 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
(84,838 |
) |
|
$ |
4.49 |
|
|
|
|
|
|
|
|
|
| Expired / Cancelled |
|
|
(130,000 |
) |
|
$ |
7.50 |
|
|
|
|
|
|
|
|
|
| Outstanding and exercisable, June 30, 2017 |
|
|
475,133 |
|
|
$ |
4.20 |
|
|
|
1.05 |
|
|
$ |
8,413 |
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
(35,773 |
) |
|
$ |
3.88 |
|
|
|
|
|
|
|
|
|
| Expired / Cancelled |
|
|
(1,000 |
) |
|
$ |
16.00 |
|
|
|
|
|
|
|
|
|
| Outstanding and exercisable, September 30, 2017 |
|
|
438,360 |
|
|
$ |
4.20 |
|
|
|
0.81 |
|
|
$ |
- |
|
The following table summarizes information about stock options and
warrants outstanding and exercisable at September 30, 2017.
| Exercise Price |
|
|
Number Outstanding and Exercisable |
|
|
Weighted Average Remaining Contractual Life |
|
|
Weighted Ave Exercise Price |
|
| OPTIONS: |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
| $ |
3.88 |
|
|
|
384,898 |
|
|
|
0.74 |
|
|
$ |
3.88 |
|
| $ |
6.50 |
|
|
|
53,462 |
|
|
|
1.35 |
|
|
$ |
6.50 |
|
| Totals |
|
|
|
438,360 |
|
|
|
0.81 |
|
|
$ |
4.20 |
|
The following table summarizes stock grants awarded as compensation:
| |
|
# of shares |
|
|
Weighted
Average Grant
Date Fair Value ($)
|
|
| |
|
|
|
|
|
|
| Unvested, June 30, 2016 |
|
|
630,228 |
|
|
$ |
6.07 |
|
| Granted |
|
|
222,146 |
|
|
$ |
5.92 |
|
| Forfeited / Cancelled |
|
|
(5,000 |
) |
|
$ |
5.55 |
|
| Vested |
|
|
(427,175 |
) |
|
$ |
5.90 |
|
| Unvested, June 30, 2017 |
|
|
420,199 |
|
|
$ |
6.07 |
|
| Vested |
|
|
(71,971 |
) |
|
$ |
5.90 |
|
| Unvested, September 30, 2017 |
|
|
348,228 |
|
|
$ |
6.16 |
|
For the three months ended September 30, 2017
and 2016, the Company recorded compensation expense of $427,809 and $865,456, respectively. The compensation expense related to
the unvested stock grants as of September 30, 2017 was $2,137,629 which will be recognized during the fiscal years 2018 through
2022.
|